Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
328.00    -7.40 (-2.21%)
Bid:
326.80
Ask:
328.80
Spread: 2.00 (0.612%)
Market Cap: £718.55m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Director/PDMR Shareholding

1 Jun 2020 09:00

RNS Number : 4543O
Burford Capital Limited
01 June 2020
 

1 June 2020

BURFORD CAPITAL LIMITEDNotification of transactions by persons discharging managerial responsibilities

Burford Capital Limited ("Burford") has been notified of certain purchases of the bonds issued by Burford Capital Finance LLC (the "Company"), an indirect wholly-owned subsidiary of Burford, made by Christopher P. Bogart, Burford's Chief Executive Officer, and Jonathan Molot, Burford's Chief Investment Officer.

 

On 28 May 2020, Mr Bogart purchased 5,000 6.125% US Dollar denominated bonds due 12 August 2025 issued by the Company ("Bonds") and Mr Molot also purchased 5,000 Bonds, in each case at a price of US$87.375 per Bond.

 

The Notification of Dealing Forms for each of the transactions mentioned above are included at the end of this announcement.

 

 

For further information, please contact:

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Alex Reynolds

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

 

About Burford Capital Finance LLC

 

Burford Capital Finance LLC is a special purpose financing vehicle created to issue Burford's 2018 US Dollar denominated retail bonds and an indirect wholly‐owned subsidiary of Burford.

 

About Burford Capital Limited

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Christopher Bogart

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Executive Officer of Burford Capital Limited

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Finance LLC

(b) LEI

549300L30WEIAK4ZUX81

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

6.125 per cent. US Dollar denominated bonds due 2025 at 100 per cent. of their principal amount

("Bonds")

Identification code

XS1756325228

(b) Nature of the transaction

Purchase of Bonds

(c) Price(s)and volume(s)

Price(s)

Volume(s)

US$87.375

5,000

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

28 May 2020

(f) Place of the transaction

Outside of a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a) Name

Jonathan Molot

2

Reason for the notification

(a) Position/status

A PDMR occupying the position of Chief Investment Officer of Burford Capital Limited

(b) Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a) Name

Burford Capital Finance LLC

(b) LEI

549300L30WEIAK4ZUX81

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) Description of the financial instrument, type of instrument

6.125 per cent. US Dollar denominated bonds due 2025 at 100 per cent. of their principal amount

(the "Bonds")

Identification code

XS1756325228

(b) Nature of the transaction

Purchase of Bonds

(c) Price(s)and volume(s)

Price(s)

Volume(s)

US$87.375

5,000

(d) Aggregated information

· Aggregated volume

· Price

N/A

(e) Date of the transaction

28 May 2020

(f) Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKFLFXBELEBBZ
Date   Source Headline
6th Jun 20241:00 pmRNSCompleted Purchases of Shares
3rd Jun 20241:00 pmRNSIntended Purchases of Ordinary Shares
31st May 20241:30 pmRNSSterling FX Rate for 2023 Final Dividend
31st May 20241:00 pmRNSDirector/PDMR Shareholding
29th May 20241:00 pmRNSDirector/PDMR Shareholding
20th May 202412:00 pmRNSResult of AGM
13th May 202412:00 pmRNS1Q24 Results & Quarterly Report
9th May 20247:00 amRNSNotice of 1Q24 Results & Results Call Details
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.